| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |